Eucrates Biomedical Acqui...

NASDAQ: EUCRU · Real-Time Price · USD
10.02
-0.07 (-0.69%)
At close: Apr 26, 2023, 9:59 PM

Eucrates Biomedical Acquisition Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2022 FY 2021
Period Ending Dec 31, 2022 Dec 31, 2021
PE Ratio
5.37 7.60
PEG Ratio
0.12 0.00
PS Ratio
n/a n/a
PB Ratio
3.49 0.29
P/FCF Ratio
-47.22 -57.91
P/OCF Ratio
-47.22 -57.91
OCF/S Ratio
n/a n/a
Debt / Equity Ratio
0.01 n/a
Quick Ratio
2.03 6.87
Current Ratio
2.03 6.87
Asset Turnover
n/a n/a
Interest Coverage
n/a n/a
Return on Equity
0.65 0.04
Return on Assets
0.44 0.04
Return on Invested Capital
-0.13 -0.01
Dividend Yield
n/a n/a
Payout Ratio
n/a n/a
Gross Profit Margin
n/a n/a
Net Profit Margin
n/a n/a
Pretax Profit Margin
n/a n/a
Operating Profit Margin
n/a n/a
FCF Margin
n/a n/a
EBITDA Margin
n/a n/a